Infections in diabetes

Infectious Disease Clinics of North America

Volumn 15, Issue 2, 2001, Pages 407-421

  Calvet, Helene M ^a,c   Yoshikawa, Thomas T ^b,c  

^a Weill Cornell Medicine   (United States)

^b Department of Internal Medicine ^*

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; CELLULAR IMMUNITY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC FOOT; GASTROINTESTINAL INFECTION; HEAD AND NECK INFECTION; HUMAN; HUMORAL IMMUNITY; INFECTION; INFECTION RISK; LUNG INFECTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 0034957853     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70153-7     Document Type: Article

References (64)

1. Immunizations for immunocompromised adults
2. Molecular mechanisms of diabetic complications
3. Targeted tuberculin testing and treatment of latent tuberculosis infection
4. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: A retrospective study
5. Current concepts: Assessment and management of foot disease in patients with diabetes
6. Impaired leucocyte function in diabetic patients
7. Infections in the diabetic patient: Strategies for the clinician
8. Uroradiology of diabetes mellitus
9. Spectrum of gas within the kidney: Emphysematous pyelonephritis and emphysematous pyelitis
10. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient
11. Prognosis and outcomes of patients with community-acquired pneumonia
12. Urinary tract infections in patients with diabetes mellitus: Studies on antibody coating of bacteria
13. The treatment of urinary tract infections in women with diabetes mellitus
14. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum
15. Neutrophil bactericidal function in diabetes mellitus: Evidence for association with blood glucose control
16. Immune dysfunction in patients with diabetes mellitus
17. Ciprofloxacin in the treatment of malignant external otitis
18. A review of selective infections in the adult diabetic
19. Probing to bone in infected pedal ulcers
20. Prospective study of the aetiology of adult community acquired bacterial pneumonia needing hospitalization in Singapore
21. Foot infections in diabetes: Evaluation and management
22. Asymptomatic infections of the urinary tract
23. Renal emphysema
24. Pulmonary complications of diabetes mellitus: Pneumonia
25. Evidence-based antibiotic therapy of diabetic foot infections
26. Osteomyelitis of the foot in diabetic patients
27. Factors affecting staphylococcal colonization among NIDDM outpatients
28. Pharyngeal colonization by gram-negative bacilli in aspiration-prone persons
29. A comparative appraisal of emphysematous cholecystitis
30. Rhinocerebral mucormycosis: Premortem diagnosis and therapy
31. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients
32. Diabetes mellitus, antisecretory drugs and other risk factors for Campylobacter gastro-enteritis in adults: A case-control study
33. Unsuspected osteomyelitis in diabetic foot ulcers: Diagnosis and monitoring by leukocyte scanning with indium 111 oxyquinoline
34. Primary care: Infections in patients with diabetes mellitus
35. The continuing challenge of Fournier's gangrene
36. Prevalence and site of bacteriuria in diabetes mellitus
37. The role of diabetes in the higher prevalence of tuberculosis among hispanics
38. Bacterial urinary tract infections in diabetes
39. Bacterial urinary tract infections in diabetes
40. Gangrene and Fournier's gangrene
41. Rhinocerebral mucormycosis following donor leukocyte infusion: Successful treatment with liposomal amphotericin B and surgical debridement
42. Rhinocerebral mucormycosis: Evolution of the disease and treatment options
43. Early postoperative glucose control predicts infection rate in diabetic patients
44. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients
45. The cause of death in diabetes: A report of 307 autopsied cases
46. Malignant external otitis: Insights into pathogenesis, clinical manifestations, diagnosis and therapy
47. Ciprofloxacin treatment of malignant external otitis
48. Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery
49. Infections in the diabetic patient
50. Rhinocerebral mycosis in immunocompromised patients: A case report and review of the literature
51. Emphysematous pyelonephritis caused by Candida tropicalis
52. Deep soft tissue infections in diabetic patients
53. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy
54. Infections emergencies in patients with diabetes mellitus
55. Management of urinary tract infections in adults
56. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputations
57. Diabetes mellitus - A newly described risk factor for infection from Salmonella enteritidis
58. Perinephric abscess
59. Infections of the head and neck in diabetes mellitus
60. Skin and skin structure infections in the patient at risk: Carrier state of Staphylococcus aureus
61. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus
62. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
63. Infection and diabetes mellitus
64. Glucose control lowers the risk of wound infection in diabetics after open heart operations